MENINGITIS VACCINE – MENINGOCOCCAL VACCINE – MENINGITIS VACCINATION – MENINGITIS IMMUNIZATION

 
FOR HEALTH CARE PROVIDERS
Meningococcal Disease
Why you should vaccinate adults against meningococcal disease
  • Up to 2,800 Americans get meningococcal disease every year; about 10 percent will die, even with rapid and appropriate treatment.

  • Two in 10 survivors will have serious long-term and permanent sequelae including hearing loss, brain damage, renal failure or limb amputations.

  • The early symptoms of meningitis infection might be mild and similar to symptoms of less severe infections, like the flu, which can lead to missed diagnosis.
 
Read More
For more information about meningococcal disease, click here.
 
Contact Us  |  About NFID  |  Adult Immunization Report  |  Supporting Organizations This Web site is supported by unrestricted educational grants to the National Foundation for Infectious Diseases from GlaxoSmithKline, Merck & Co., Inc., sanofi pasteur and Wyeth Pharmaceuticals.